PR Newswire
TORONTO
,
May 12
, 2022
/PRNewswire/ – TerrAscend Corp. (“TerrAscend” or the “Company”) (CSE: TER) (OTCQX: TRSSF), a leading North American cannabis operator, today reported its financial results for the first quarter ending
March 31, 2022
. All amounts are expressed in U.S. dollars unless indicated otherwise and are prepared under U.S. Generally Accepted Accounting principles (GAAP).
First Quarter 2022 Financial Highlights
-
Net Sales
were
$49.7 million
as compared to
$49.2 million
in Q4 2021. -
Gross Profit Margin
was 30.5% as compared to 42.3% in Q4 2021. -
Adjusted Gross Profit
Margin
1
was 38.4% as compared to 49.8% in Q4 2021. -
Adjusted EBITDA
1
was
$3.3 million
as compared to
$11.9 million
in Q4 2021. -
Adjusted EBITDA
Margin
1
was 6.6% as compared to 24.2% in Q4 2021. -
Cash and Cash Equivalents
totaled
$88.4 million
as of
March 31, 2022
.
Jason Wild
, Executive Chairman of TerrAscend, commented, “While revenue and margins during the first quarter were impacted by the industry wide vape recall in
Pennsylvania
and front-loaded operating costs in
New Jersey
ahead of adult use, we expect revenue and margin to increase materially in the second quarter and beyond. The strategic decisions and investments we have made over the last three years position us well for substantial growth in each of our four key markets –
New Jersey
,
Pennsylvania
,
Michigan
and
Maryland
.”
Mr. Wild continued, ”
New Jersey
adult use sales began on
April 21
st
, a significant milestone for TerrAscend and the entire industry. Demand has been strong for our brands and our elevated retail experience. We recently introduced the first concentrates in the state and expect additional ‘first-in-state’ product introductions in the near future. In
Pennsylvania
, we continue to cultivate the highest quality flower in our history and have introduced new genetics, to which patients have reacted positively. In
Michigan
, Gage has positioned us as a leader in one of the largest cannabis markets in the U.S. Lastly, subsequent to the quarter end, we announced the acquisition of a medical dispensary in
Maryland
and 5 dispensaries in
Michigan
. These acquisitions exemplify our strategy of ‘going deep’ in the markets in which we operate. While remaining focused on organic growth, the dislocation in public and private company valuations should provide attractive M&A opportunities to accelerate growth in a financially disciplined way.”
Financial Summary Q1 2022 and Comparative Periods
|
|
|
|
|
|||||||||||||||||
|
|
|
|
|
|||||||||||||||||
|
|
|
|
|
|||||||||||||||||
|
|
|
|
|
|||||||||||||||||
|
|
|
|
|
|||||||||||||||||
|
|
|
|
|
|||||||||||||||||
|
|
|
|
|
|||||||||||||||||
|
|
|
|
|
|||||||||||||||||
|
|
|
|
|
|||||||||||||||||
|
|
|
|
|
|||||||||||||||||
|
|
|
|
|
|||||||||||||||||
|
|
|
|
|
|||||||||||||||||
|
|
|
|
|
|||||||||||||||||
|
|
|
|
|
|||||||||||||||||
|
|
First Quarter 2022 Business and Operational Highlights
- Closed on the acquisition of Gage Growth Corp.
-
Appointed
Ziad Ghanem
as President and Chief Operating Officer. -
Appointed
Jared Anderson
, SVP Finance & Strategy,
Charishma Kothari
, SVP Marketing, and
Charles Oster
, SVP Sales. -
Appointed
Kara DioGuardi
to the Board of Directors. - Became first major MSO to expand its ecommerce platform via proprietary Apothecarium mobile app, available in the Apple App store, with express pick-up and delivery where permitted.
Subsequent Events
-
Held the grand opening of adult-use sales on
April 21
st
in
Maplewood
and
Phillipsburg, New Jersey
, two of only twelve dispensaries currently opened in the state. - Approved for hydrocarbon extraction in New Jersery with first products recently launched.
-
Signed lease on new facility in
New Jersey
, which will provide expanded capacity up to the 150,000 canopy square foot limit. -
Received home delivery license for medical patients in
New Jersey
. -
Partnered with Cookies to open its third Cookies-branded dispensary in
Michigan
, located in
Ann Arbor
. -
Announced agreement to acquire KISA Enterprises MI, LLC and KISA Holdings, LLC (“Pinnacle”), a dispensary operator in
Michigan
with 5 operational locations. -
Extraction lab and packaging facilities in
Michigan
approved to start operations. -
Announced acquisition of Allegany Medical Marijuana Dispensary (“AMMD”) located in
Cumberland, MD
, which will enable the Company to become vertically integrated in the state. -
Announced the promotion of
Jodie Lampert
to SVP of Human Resources and the appointment of
Lynn Gefen
as Chief Legal Officer and Corporate Secretary.
First Quarter 2022 Financial Results
Net sales for the first quarter of 2022 totaled
$49.7 million
, up 1% sequentially and down 7% year over year, mainly related to the temporary impact of the vape recall on the
Pennsylvania
business, combined with the continued intentional accumulation of inventory in
New Jersey
, versus selling wholesale, in preparation for adult use sales. The Company’s Canadian business also experienced a soft quarter both sequentially and year over year. The declines were partially offset by three weeks of revenue from the Gage acquisition, which closed on
March 10th
.
Gross margin for the quarter was 30.5% as compared to 42.3% in the previous quarter. Adjusted gross margin for the quarter, excluding one-time impacts such as reserves for the
Pennsylvania
vape recall in the first quarter, was 38.4% as compared to 49.8% in the previous quarter. The sequential margin compression was driven by the under-absorption impact of lower volumes related to the vape recall in
Pennsylvania
, front loaded costs in
New Jersey
ahead of adult use sales, and an unfavorable mix from the addition of Gage.
General & Administrative expenses, excluding stock-based compensation, were up
$2.2 million
, including Gage, versus the previous quarter. As a percentage of revenue, G&A increased to 38.7% in the first quarter of 2022 from 34.5% in fourth quarter of 2021. The increase as a percentage of revenue was impacted by flat revenue combined with front-loaded spending in
New Jersey
ahead of adult use and the addition of Gage for part of the quarter.
Adjusted EBITDA for the quarter was
$3.3 million
versus
$11.9 million
in the previous quarter. This reduction was mainly driven by gross margin compression in
Pennsylvania
related to lower volumes and front-loaded costs in
New Jersey
ahead of adult use sales, as well as intentional accumulation of inventory in the state in preparation for adult use sales.
Operating loss for the quarter was
$10.0 million
, driven by the mix of revenue resulting in compressed gross margin.
Net loss for the quarter was
$16.0 million
, mainly driven by the operating loss, accrued income taxes of
$3.7 million
, and finance and other expenses of
$6.9 million
, partially offset by a net gain on fair value of warrant liability of
$5.7 million
.
Balance Sheet and Cash Flow
Cash and cash equivalents were
$88.4 million
as of
March 31, 2022
, compared to
$79.6 million
as of
December 31, 2021
, providing ample capacity to fund planned organic and inorganic growth initiatives.
Cash used from operations was
$18.8 million
for the three months ended
March 31, 2022
, mainly driven by working capital as the Company continued to prepare for adult use sales in
New Jersey
, as well as
$8 million
of interest payments. The Company received
$23.9 million
in proceeds from warrants and options during the quarter while paying
$3.3 million
to terminate the lease in
Frederick, Maryland
in preparation for the transition to the new facility in Hagerstown. A payment of
$7.0 million
was also made for the final earnout related to the acquisition of the State Flower business.
Capital expenditures were
$4.2 million
in the quarter, primarily related to the on-going expansion work at the
Hagerstown, Maryland
facility.
As of
May 11
th
, 2022 there were 318.4 million basic shares outstanding including 252 million common shares, 14 million preferred shares as converted, and 52.4 million exchangeable shares.
Conference Call
TerrAscend will host a conference call today,
May 12, 2022
, to discuss these results.
Jason Wild
, Executive Chairman;
Ziad Ghanem
, President and Chief Operating Officer and
Keith Stauffer
, Chief Financial Officer will host the call starting at
6:00 p.m. Eastern time
. A question-and-answer session will follow management’s presentation.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial results and analyses are available on the Company’s website (
www.terrascend.com
) and SEDAR (
www.sedar.com
).
The Canadian Securities Exchange (“CSE”) has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
Definition and Reconciliation of Non-GAAP Measures
In addition to reporting the financial results in accordance with GAAP, the Company reports certain financial results that differ from what is reported under GAAP. Non-GAAP measures used by management do not have any standardized meaning prescribed by GAAP and may not be comparable to similar measures presented by other companies. The Company believes that certain investors and analysts use these measures to measure a company’s ability to meet other payment obligations or as a common measurement to value companies in the cannabis industry, and the Company calculates Adjusted Gross Profit as Gross Profit adjusted for certain material non-cash items and Adjusted EBITDA as EBITDA adjusted for certain material non-cash items and certain other adjustments management believes are not reflective of the ongoing operations and performance. Such information is intended to provide additional information and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with GAAP. The Company believes this definition is a useful measure to assess the performance of the Company as it provides more meaningful operating results by excluding the effects of expenses that are not reflective of the Company’s underlying business performance and other one-time or non-recurring expenses.
The table below reconciles Gross Profit and Adjusted Gross Profit for the quarters ended
March 31, 2022
,
December 31, 2021
, and
March 31, 2021
|
|
||||||||||||
|
|
|
|
|
|||||||||
|
|
|
|
|
|||||||||
|
|
||||||||||||
|
|
|
|
|
|||||||||
|
|
|
|
|
|||||||||
|
|
|
|
|
|||||||||
|
|
|
|
|
|||||||||
|
|
|
|
|
|||||||||
The table below reconciles net loss to EBITDA and Adjusted EBITDA for the quarters ended
March 31, 2022
,
December 31, 2021
, and
March 31, 2021
|
|
||||||||||||
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
||||||
|
|
||||||||||||
|
|
|
|
|
|||||||||
|
|
|
|
|
|||||||||
|
|
|
|
|
|||||||||
|
|
|
|
|
|||||||||
|
|
||||||||||||
|
|
|
|
|
|||||||||
|
|
|
|
|
|||||||||
|
|
|
|
||||||||||
|
|
|
|
|
|||||||||
|
|
|
|
|
|||||||||
|
|
|
|
|
|||||||||
|
|
|
|
|
|||||||||
|
|
|
|
|
|||||||||
|
|
|
|
|
|||||||||
|
|
|
|
|
|||||||||
|
|
|
|
|
|||||||||
|
|
|
|
|
|||||||||
|
|
|
|
|
|||||||||
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
||||||
About TerrAscend
TerrAscend is a leading North American cannabis operator with vertically integrated operations in Pennsylvania, New Jersey, Michigan and California, licensed cultivation and processing operations in Maryland and licensed production in Canada. TerrAscend operates The Apothecarium and Gage dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core markets. TerrAscend’s cultivation and manufacturing practices yield consistent, high-quality cannabis, providing industry-leading product selection to both the medical and legal adult-use markets. The Company owns several synergistic businesses and brands, including Gage Cannabis, The Apothecarium, Ilera Healthcare, Kind Tree, Prism, State Flower, Valhalla Confections, and Arise Bioscience Inc. For more information, visit
www.terrascend.com
.
Caution Regarding Cannabis Operations in
the United States
Investors should note that there are significant legal restrictions and regulations that govern the cannabis industry in the
United States
. Cannabis remains a Schedule I drug under the US Controlled Substances Act, making it illegal under federal law in the United States to, among other things, cultivate, distribute, or possess cannabis in the
United States
. Financial transactions involving proceeds generated by, or intended to promote, cannabis-related business activities in the United States may form the basis for prosecution under applicable US federal money laundering legislation.
While the approach to enforcement of such laws by the federal government in the United States has trended toward non-enforcement against individuals and businesses that comply with medical or adult-use cannabis programs in states where such programs are legal, strict compliance with state laws with respect to cannabis will neither absolve TerrAscend of liability under U.S. federal law, nor will it provide a defense to any federal proceeding which may be brought against TerrAscend. The enforcement of federal laws in the United States is a significant risk to the business of TerrAscend and any proceedings brought against TerrAscend thereunder may adversely affect TerrAscend’s operations and financial performance.
Forward Looking Information
This news release contains “forward-looking information” within the meaning of applicable securities laws. Forward-looking information contained in this press release may be identified by the use of words such as, “may”, “would”, “could”, “will”, “likely”, “expect”, “anticipate”, “believe, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook” and other similar expressions, and include statements with respect to future revenue and profits. Forward-looking information is not a guarantee of future performance and is based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors relevant in the circumstances, including assumptions in respect of current and future market conditions, the current and future regulatory environment, and the availability of licenses, approvals and permits.
Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information. Such risks and uncertainties include, but are not limited to, current and future market conditions; risks related to federal, state, provincial, territorial, local and foreign government laws, rules and regulations, including federal and state laws in
the United States
relating to cannabis operations in
the United States
; and the risk factors set out in the Company’s most recently filed MD&A, filed with the Canadian securities regulators and available under the Company’s profile on SEDAR at
www.sedar.com
.
The statements in this press release are made as of the date of this release. The Company disclaims any intent or obligation to update any forward-looking information, whether, as a result of new information, future events, or results or otherwise, other than as required by applicable securities laws.
Unaudited Interim Condensed Consolidated Balance Sheets
(Amounts expressed in thousands of
United States
dollars, except for per share amounts)
|
|
|
|||||||
|
|
|
|||||||
|
|
||||||||
|
|
||||||||
|
|
|
|
|
|
||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|||||||
|
|
||||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|||||||
|
|
|
|
|
|
||||
|
|
||||||||
|
|
||||||||
|
|
|
|
|
|
||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|||||||
|
|
||||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|||||||
|
|
|
|
||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
|
|
||||
Unaudited Interim Condensed Consolidated Statements of Operations and Comprehensive Loss
(Amounts expressed in thousands of
United States
dollars, except for per share amounts)
|
|
|||||||
|
|
|
||||||
|
|
|
|
|
|
|||
|
|
|
|
|||||
|
|
|
|
|||||
|
|
|
|
|||||
|
|
|
|
|||||
|
|
|||||||
|
|
|
|
|||||
|
|
|
|
|||||
|
|
|
|
|||||
|
|
|
|
|||||
|
|
|||||||
|
|
|
|
|||||
|
|
|
|
|||||
|
|
|
|
|||||
|
|
|
|
|||||
|
|
|
|
|||||
|
|
|
|
|||||
|
|
|
|
|||||
|
|
|
|
|||||
|
|
|
|
|
|
|||
|
|
|
|
|||||
|
|
|
|
|
|
|||
|
|
|||||||
|
|
|
|
|
|
|||
|
|
|
|
|
||||
|
|
|||||||
|
|
|
|
|
|
|||
|
|
|
|
|
||||
|
|
|||||||
|
|
|
|
|
|
|||
|
|
|
|
|||||
|
|
|
|
|
|
|||
|
|
|
|
|||||
Unaudited Interim Condensed Consolidated Statements of Cash Flows
(Amounts expressed in thousands of
United States
dollars, except for per share amounts)
|
|
||||||||
|
|
|
|||||||
|
|
||||||||
|
|
|
|
||||||
|
|
||||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
||||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
||||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
||||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
||||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
||||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
View original content:
https://www.prnewswire.com/news-releases/terrascend-reports-first-quarter-2022-financial-results-301546571.html
SOURCE TerrAscend
